Skip to main content

Publications

featured publications

  • Accumulating Evidence Supports NECTIN4 as a Predictive Biomarker for Enfortumab Vedotin: The Compartment Still Matters.

    European urology

    Authors: Niklas Klümper, Jonathan E Rosenberg, David H Aggen, Markus Eckstein

  • Re-evaluating aglatimagene in localised prostate cancer.

    The Lancet. Oncology

    Authors: Thomas Büttner, Davide Scafa, Julian P Layer, Manuel Ritter, Glen Kristiansen, Markus Eckstein, Niklas Klümper

  • Integrating NECTIN4 Amplification With Membranous Nectin-4 Expression to Develop a Scoring System for Predicting Enfortumab Vedotin Response in Urothelial Carcinoma.

    Clinical cancer research : an official journal of the American Association for Cancer Research

    Authors: Niklas Klümper, Thomas Büttner, Sebastian Rauch, Stefanie Zschäbitz, Florian Roghmann, Christian Bolenz, Fabienne Lange, Patricia Rausch, Friedemann Zengerling, Nadine Gaisa, Oliver Hahn, Constantin Schwab, Anna Scherping, Marieta Toma, Hendrik Heers, Phillipp Ivanyi, Guenter Niegisch, Camilla Marisa Grunewald, Christopher Darr, Pia Paffenholz, Richard Weiten, Susanne Füssel, Christian Thomas, Marcus Sondermann, Ulrich Sommer, Kerstin Junker, Katrin Schlack, Jozefina Casuscelli, Can Aydogdu, Dora Niedersüß-Beke, Steffen Rausch, Christoph Kuppe, Joshua Meeks, Bonnie Choy, Sarmad Sadeghi, Parkash Gill, Manuel Ritter, Johannes Brägelmann, Michael Hölzel, Arndt Hartmann, Viktor Grünwald, Jonas Saal, Markus Eckstein

  • FASTRACK II: Expanding the Role of SABR in Localized Renal Cell Carcinoma.

    European urology

    Authors: Julian Philipp Layer, Eleni Gkika, Niklas Klümper

  • FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result Reporting.

    European urology oncology

    Authors: Eva M Compérat, Arndt Hartmann, Yves Allory, Beatriz Bellosillo, Rui Pedro Caetano Moreira Oliveira, Caterina Chiappetta, Farah Hodeib, Michael Hubank, Niklas Klümper, Yohann Loriot, Frédérique Penault-Llorca, Astrid Rijken, Ernst-Jan M Speel, Bernadett Szabados, Isabelle Vanden Bempt, Geert J L H Van Leenders, Mariavittoria Vescovo, Markus Eckstein

  • Effectiveness and safety of enfortumab vedotin and pembrolizumab in a real-world patient population with urothelial carcinoma: results from a multi-institutional cohort (GUARDIANS).

    Cancer immunology, immunotherapy : CII

    Authors: Stefanie Zschäbitz, Irfan Bhatti, Jozefina Casuscelli, Ludwig Otto Pachmayr, Thomas Büttner, Thomas Elegeert, Nina Holzwarth, Severin Rodler, Martin Hennig, Emily Rinderknecht, Muammar Dib, Katrin Schlack, Christopher Darr, Anna-Lisa Volk, Philipp Schmucker, Friedemann Zengerling, Pia Paffenholz, Joschka Heil, Eva Erne, Subhajit Mandal, Frederik Wessels, Thea Maria Busse, Daniel Seidl, Susan Foller, Alexander Höllein, Tim Nestler, Christian Gratzke, Louis Rhode, Jakob Kohler, Günter Niegisch, Anna Katharina Seitz, Julia Heinzelbecker, Niklas Klümper, Margitta Retz, Viktor Grünwald, Can Aydogdu, Marco Julius Schnabel

  • Spatial Multiomics Reveal Insights Into ADC Efficacy.

    European journal of immunology

    Authors: Osman Goni, Niklas Klümper, Maria Del Mar Muñiz Moreno, Markus Eckstein, Christoph Kuppe

  • Combined elevation of pre-treatment γ-glutamyltransferase and lactate dehydrogenase as independent prognosticator for metastatic renal cell carcinoma undergoing immune-based therapy.

    Scientific reports

    Authors: Annemarie Uhlig, Angelika Mattigk, Marcus Sondermann, Benedikt Hoeh, Cristina Cano Garcia, Niklas Klümper, Alexander Cox, Oliver Hahn, Philipp Schmucker, Luka Flegar, Jonathan Vollemaere, Friedemann Zengerling, Severine Banek, Jörg Ellinger, Johannes Huber, Philip Zeuschner, Charis Kalogirou, Kati Erdmann

  • CD3 and PD-L1 tissue expression have synergistic value in head and neck squamous cell carcinoma prognosis.

    Translational oncology

    Authors: Adrian V Witzleben, Romain Remark, Christian Idel, Julika Ribbat-Idel, Rosemarie Krupar, Andreas Schröck, Niklas Klümper, Johannes Doescher, Andrew G Sikora, Tsima Abou Kors, Julius M Vahl, Matthias Brand, Michael Sonntag, Cornelia Brunner, Thomas K Hoffmann, Sven Perner, Sacha Gnjatic, Simon Laban

  • Bellmunt Risk Score as a Prognostic Tool in Metastatic Castration-Resistant Prostate Cancer Survival.

    JAMA network open

    Authors: Thomas Büttner, Niklas Klümper, Jörg Ellinger, Manuel Ritter, Philipp Krausewitz